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Abstract
The 6-minute walk test (6MWT) is a simple field test that is widely used in clinical settings to assess functional exercise capacity.
However, studies with healthy subjects are scarce. We hypothesized that the 6MWTmight be useful to assess exercise capacity
in healthy subjects. The purpose of this study was to evaluate 6MWT intensity in middle-aged and older adults, as well as to
develop a simple equation to predict oxygen uptake (
:
VO2) from the 6-min walk distance (6MWD). Eighty-six participants, 40
men and 46 women, 40-74 years of age and with a mean body mass index of 28±6 kg/m2, performed the 6MWT
according to American Thoracic Society guidelines. Physiological responses were evaluated during the 6MWT using a
K4b2 Cosmed telemetry gas analyzer. On a different occasion, the subjects performed ramp protocol cardiopulmonary
exercise testing (CPET) on a treadmill. Peak
:
VO2 in the 6MWT corresponded to 78±13% of the peak
:
VO2 during CPET,
and the maximum heart rate corresponded to 80±23% of that obtained in CPET. Peak
:
VO2 in CPET was adequately
predicted by the 6MWD by a linear regression equation:
:
VO2 mL?min
–1?kg–1 = –2.863+ (0.056366MWDm) (R
2=0.76).
The 6MWT represents a moderate-to-high intensity activity in middle-aged and older adults and proved to be useful for
predicting cardiorespiratory fitness in the present study. Our results suggest that the 6MWT may also be useful in
asymptomatic individuals, and its use in walk-based conditioning programs should be encouraged.
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Introduction
Cardiopulmonary exercise testing (CPET) provides an
accurate assessment of physiological responses induced by
exercise and is extremely important in the clinical environ-
ment, especially for evaluating peak oxygen uptake (
:
VO2).
Despite the confirmed validity of CPET, its application re-
mains complex, expensive, and dependent on highly trained
professionals. Furthermore, CPETmay not be well tolerated
by very elderly patients or those with comorbidities. More-
over, CPET is not representative of functional capacity in
real life (1). Accordingly, simple and inexpensive ways for
assessing aerobic exercise capacity should be investigated
that are complementary to CPET.
The 6-min walk test (6MWT) is a simple field walking test
that is widely used in clinical settings to assess functional
exercise capacity. A great advantage of the 6MWT is its
operational simplicity. The 6-min walk distance (6MWD) is
often used as an index of cardiorespiratory fitness and has
been validated in several populations of patients with
chronic diseases (2-4). However, there is little information
regarding intensity and physiological responses to field
walking tests in healthy individuals, especially in middle-aged
adults. Accordingly, we hypothesized that the 6MWT might
also be used as a test of sufficient intensity to assess aerobic
capacity and prescribe walking programs for health promotion
in middle-aged adults and seniors without chronic disease.
Therefore, we aimed to evaluate the intensity of 6MWT in
middle-aged and older adults and to develop a simple equation
to predict their oxygen uptake (
:
VO2) from the 6MWD.
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Material and Methods
Participants
We conducted a cross-sectional study in 86 partici-
pants selected from the EPIMOV Study (Epidemiological
Study of HumanMovement and Hypokinetic Diseases) and
enrolled 40 men and 46 women from 40 to 74 years of age.
The Universidade Federal de Sa˜o Paulo Ethics Committee
approved the study, and all participants provided written
informed consent.
We recruited a convenience sample. Participants who
required a walking aid, had abnormal post-bronchodilator
lung function (5), or reported having cardiorespiratory, meta-
bolic, neuromuscular, or musculoskeletal disease were ex-
cluded from the study.
The participants completed a physical activity readiness
questionnaire (PAR-Q) (6) consisting of seven (yes/no)
questions about key risk factors for events during exercise.
If the participant answered ‘‘yes’’ to one or more questions,
then he/she was carefully evaluated by a physician before
starting the exercise protocol. A face-to-face interview
based on the main cardiovascular risk factors and the
physical activity level was also performed. Patients under-
went spirometric testing and anthropomorphic measure-
ments were recorded.
Anthropometrics
Body mass (kg) and stature (m) were measured with
participants wearing light clothing and no shoes. The body
mass index (BMI, kg/m2) was then calculated.
Spirometry
Spirometry was performed using a hand-held spirom-
eter (Quark PFT, Cosmed, Italy) according to the criteria
established by the American Thoracic Society (ATS) (5).
Forced expiratory volume in 1 sec (FEV1), forced vital
capacity (FVC), and the FEV1/FVC ratio were measured.
6MWT
The 6MWT was performed according to ATS standards
(7) at 30-min intervals. The participants were instructed to
walk as far as possible for 6 min in a 30-m hallway and were
given standardized verbal encouragement every minute.
6MWDs were recorded in meters and as a percentage of
reference values for further analysis (8). Before and after
the test, the rate of perceived exertion (dyspnea and leg
fatigue) was measured using the Borg CR10 scale (9).
Throughout the 6MWT, expired gases were collected
and analyzed with a commercially available portable tele-
metric gas analyzer (K4b2, Cosmed). The gas analyzer,
which weighs a total of less than 1 kg, was attached to the
participants by shoulder straps, allowing freemovement with
no discomfort. The manufacturer’s recommendations were
followed with regard to room air, reference gas, 3-L syringe,
and delay calibrations.
The following variables were measured at the peak of
the 6MWT: pulmonary oxygen uptake (
:
VO2), carbon dioxide
production (
:
VCO2), heart rate (HR), and minute ventilation
(
:
VE). Data were averaged every 15 s.
Cardiopulmonary exercise testing
Cardiopulmonary exercise testing (CEPT) was per-
formed on a treadmill (ATL, Imbramed, Brazil) on a different
day. The laboratory temperature was standardized at 226C.
Participants were instructed to avoid vigorous physical
activity on the day prior to the test, to avoid caffeine and
other stimulants, and heavy foods, only on the day of the
test, and to wear suitable clothing. After 3 min of rest, the
subjects were tested using a ramp protocol with individual-
ized increases in velocity and inclination until exhaustion
according to predicted peak
:
VO2.
Ventilatory, cardiovascular and metabolic responses
were continuously monitored during the CPET using a gas
analyzer (Quark PFT, Cosmed). The following variables
were collected and analyzed: heart rate (HR), oxygen
uptake (
:
VO2), carbon dioxide production (
:
VCO2), and ex-
pired minute volume (
:
VE). The average
:
VO2 obtained in
the last 15 s of the test was considered peak
:
VO2. Oxygen
uptake at lactate threshold (
:
VO2LT) was estimated using
both the gas exchange V-slope and ventilatory techniques,
as previously described (10).
Statistical analysis
Multiple linear regression analysis was used to evaluate
the association between 6MWD and CPET at peak
:
VO2
adjusted for the influence of age, gender and BMI. Following
the multiple regression analysis, we determined that the
above covariates did not significantly modify the coeffici-
ent of determination (R2). In this context, the results are
presented as a simple linear regression using the peak
:
VO2
from CPET and the 6MWD as an outcome predictor. The
intensity of the 6MWT was assessed using the t test to
compare peakHR and peak
:
VO2 in the 6MWTwith peakHR
and peak
:
VO2 in CPET. Unless otherwise specified, 2-tailed
P-values ,0.05 were considered statistically significant.
Table 1. General characteristics of the study sample (n=86).
Age (years) 54 ± 10
Gender (%; M/F) 46.6/53.4
Weight (kg) 76 ± 19
Height (cm) 1.67 ± 0.10
BMI (kg/m2) 27 ± 5
FVC (% pred.) 96 ± 12
FEV1 (% pred.) 94 ± 13
FEV1/FVC (%) 81 ± 6
6MWD (m) 608 ± 97
6MWD (% pred.) 106 ± 13
Data are reported as means±SD. BMI: body mass index; FVC:
forced vital capacity; FEV1: forced expiratory volume in 1 s;
6MWD: distance walked in 6-min walk test.
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Results
We enrolled 86 participants in this study, none of whom
presented abnormal spirometric values. The general char-
acteristics of the study sample are reported in Table 1. The
frequencies of self-reported cardiovascular risk factor were
6.7% for hypertension, 3.7% for diabetes, 20.2% for dysli-
pidemia, 21.3% for obesity, 6.7% for smoking, and 36.0% for
sedentary lifestyle.
The comparative
:
VO2 and HR values achieved in both
the 6MWT and CPET are reported in Table 2. The peak
:
VO2 in the 6MWT corresponded to 78±13% of that in
CPET, and the maximum heart rate in the 6MWT
corresponded to 80±23% of that obtained in CPET. The
peak
:
VO2 in CPET was accurately predicted by the 6MWD
(R2=0.76) by the following linear regression equation:
:
VO2
mL?min–1?kg–1 = –2.863+ (0.05636 6MWDm) (Figure 1).
Discussion
In this study, we evaluated the intensity of 6MWT in
middle-aged and older adults and derived an equation to
predict the peak
:
VO2 achieved during CPET from the
6MWD result.
The 6MWT can be described as a moderate to high-
intensity exercise in which an HR of approximately 80% of
maximum may occur. Kervio et al. (11) obtained similar
results in 12 participants 64±1 years of age using the same
gas analyzer. The HR values reached 85% of maximum,
and the
:
VO2 peak during the third of up to five 6MWTs was
quite similar to that in the present study (23±1 mL?min-1?kg-1).
The authors also showed that the peak
:
VO2 during the
fifth 6MWT represented 80% of the peak
:
VO2 obtained in
CPET performed on a treadmill, compared with 78±13%
in the present study. The results in patients with chronic
diseases permit classification of the 6MWT as a high-
intensity or even a maximal test in some clinical situations
(12). Although the peak
:
VO2 during the 6MWT is compara-
ble to that observed in cycle ergometer CPET, the time
Table 2. Intensity of the 6-min walk test (6MWT) considering
pulmonary oxygen uptake and heart rate obtained from cardio-
pulmonary exercise testing (CPET).
CPET 6MWT
Peak
:
VO2 (mL/min)
2662 ± 885 1618 ± 543
Peak
:
VO2 (mL?min
-1?kg-1)* 35 ± 11 27 ± 6
Peak
:
VO2 (% pred.)
107 ± 24 –
HR max (bpm)* 168 ± 17 134 ± 27
HR max (% pred.) 92 ± 6 78 ± 15
Data are reported as means±SD.
:
VO2: pulmonary oxygen
uptake; HR: heart rate. * Peak
:
VO2 in 6MWT corresponded to
78±13% of peak
:
VO2 in CPET and maximum heart rate
corresponded to 80±23% of that obtained in CPET.
Figure 1. Significant relationship (P,0.001) between the 6-min walk distance (6MWD) and peak oxygen uptake in cardiopulmonary
exercise testing (CPET).
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course of themain variables follows an exponential pattern,
as was observed here and in previous studies conducted in
healthy participants and in patients with chronic disease
(11,13,14).
Results demonstrating consistent correlations between
the 6MWD and peak
:
VO2 in CPET have been described in
several previous studies (11,12,15,16). Although the 6MWT
is not a constant workload test, the walking speed reaches a
constant value from the third minute of the test onwards.
Such a characteristic makes the 6MWT less accurate than
predicting peak
:
VO2 by CPET. Despite this limitation, our
prediction equation seems to be accurate, as shown in
Figure 1. Several studies proposed that the 6MWD can
predict
:
VO2; however, those studies involved patients with
various diseases (17-19). We were able to find only one
previous study that correlated peak
:
VO2 in 6MWT with
peak
:
VO2 in CPET. Unfortunately, the authors did not
perform a CPET (14). Instead, the correlation between
peak
:
VO2 in 6MWT and CPET was assessed using a
previous reference equation for predicting peak
:
VO2 in
CPET (10). To the best of our knowledge, no study has
shown such equation in a sample of healthy individuals.
Nonlinear models for prediction of 6MWD have been
described recently (20), but their predictive power is similar
to that of linear models.
This study has some limitations. We recruited a con-
venience sample, but we took care to include only healthy
individuals not involved in sports or vigorous physical
activity. We did not find a significant influence of physical
activity level on 6MWT performance. A recent study ob-
served a significant association between the 6MWD and
physical activity level (21), despite not controlling for this
variable.
The 6MWT represents a high-intensity activity for the
majority of middle-aged and older adults, and the strong
correlation between peak
:
VO2 in the 6MWT and in CPET
observed here shows that it is suitable for assessing aerobic
functional exercise capacity in this age group. Furthermore,
the 6MWT seems to be a valid tool for prescribing walking
programs intended to improve the health of individuals in this
group. The 6MWT might provide an appropriate frame of
reference for the normalcy of physiological responses in
adults 40 years of age and older.
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